MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl)retinamide.
OBJECTIVE
MicroRNAs (miRNAs) are important regulators of many cellular functions due to their ability to target mRNAs for degradation or translational inhibition. Previous studies have reported that the expression of microRNA-9 (miR-9) is regulated by retinoic acid and reactive oxygen species (ROS). We have previously shown that N-(4-hydroxyphenyl)-retinamide (4HPR), a retinoic acid derivative, induces ROS generation and apoptosis in cultured human retinal pigment epithelial (RPE) cells, known as ARPE-19 cells. The aim of the present study was to investigate the expression of miR-9 in ARPE-19 cells in response to 4HPR treatment, and to identify other miRNAs normally expressed in these cells.


METHODS
ARPE-19 cells in culture were treated with 4HPR, the total RNA fractions were isolated, and the expression of various miRNAs and mRNAs was analyzed using real-time PCR. The miRNA expression profile of ARPE-19 cells was analyzed using microarray hybridization.


RESULTS
Treatment of ARPE-19 cells with 4HPR resulted in apoptosis characterized by the increased expression of HMOX1 and GADD153 genes. A twofold increase in the expression of miR-9 was also observed during this response. Potential binding sites for the transcription factors encoded by CEBPA and CEBPB genes were found to be present in the putative promoter regions of all three genes encoding miR-9. 4HPR-induced miR-9 expression was associated with parallel increases in the expression of these transcription factor genes. 5-Aza-2'-deoxycytidine, a methyl transferase inhibitor, also increased the expression of miR-9 in ARPE-19 cells. Microarray hybridization analysis identified let-7b, let-7a, miR-125b, miR-24, miR-320, miR-23b, let-7e, and let-7d as the most abundant miRNAs normally expressed in ARPE-19 cells. These miRNAs are known to regulate cell growth, differentiation or development. The 4HPR treatment increased the expression of miR-16, miR-26b, miR-23a, and miR-15b in ARPE-19 cells, although these increases were modest when compared to the increase in the expression of miR-9.


CONCLUSIONS
Our studies demonstrate that miR-9 is expressed in the RPE cell line ARPE-19, and its expression is increased by a retinoic acid derivative and by an inhibitor of promoter hypermethylation. Several miRNAs with inherent ability to regulate cell growth, differentiation and development are also normally expressed in ARPE-19 cells. Thus, miR-9 and other miRNAs could be important in maintaining RPE cell function.
Kutty
R Krishnan
RK
Laboratory of Retinal Cell and Molecular Biology, Bldg. 6, Room 112, National Eye Institute, National Institutes of Health, 6 Center Dr., MSC 0608, Bethesda, MD 20892, USA. kuttyk@nei.nih.gov
Samuel
William
W
Jaworski
Cynthia
C
Duncan
Todd
T
Nagineni
Chandrasekharam N
CN
Raghavachari
Nalini
N
Wiggert
Barbara
B
Redmond
T Michael
TM
D017209:Apoptosis / Q000187:drug effects; D001374:Azacitidine / Q000494:pharmacology; D001483:Base Sequence; D001665:Binding Sites; D022762:CCAAT-Enhancer-Binding Proteins / Q000378:metabolism; D002460:Cell Line; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism*; D017313:Fenretinide / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D008969:Molecular Sequence Data; D020411:Oligonucleotide Array Sequence Analysis; D018384:Oxidative Stress / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D015203:Reproducibility of Results; D012160:Retina / Q000187:drug effects / Q000378:metabolism; D055213:Retinal Pigment Epithelium / Q000166:cytology*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D022762:CCAAT-Enhancer-Binding Proteins; C541874:MIRN92 microRNA, human; D035683:MicroRNAs; D017313:Fenretinide; D001374:Azacitidine
Genome Biol. 2004;5(3):R13
15003116
FASEB J. 2010 May;24(5):1552-71
20056717
Neuroreport. 2007 Feb 12;18(3):297-300
17314675
Blood. 2008 Jan 15;111(2):588-95
17906079
J Neurosci. 2008 Oct 8;28(41):10415-21
18842901
Trends Mol Med. 2008 Sep;14(9):400-9
18674967
RNA. 2003 Oct;9(10):1274-81
13130141
Int J Cancer. 2009 Dec 1;125(11):2737-43
19521961
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6415-20
18434550
Nature. 2004 Sep 16;431(7006):350-5
15372042
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13513-8
17686970
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15221-6
11752465
Trends Cell Biol. 2008 Oct;18(10):505-16
18774294
Exp Hematol. 2009 Feb;37(2):245-55
19135902
J Biol Chem. 2009 Jun 19;284(25):16939-16947
19386604
J Biol Chem. 2007 Aug 24;282(34):25053-66
17597072
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5282-7
19289835
J Neurosci. 2008 Dec 31;28(53):14341-6
19118166
Cancer Res. 2009 Jul 15;69(14):5936-45
19549897
Mol Vis. 2006 Oct 17;12:1175-84
17102797
Med Oncol. 2010 Sep;27(3):654-60
19572217
Dev Dyn. 2006 Sep;235(9):2538-48
16736490
Genes Dev. 2009 Apr 1;23(7):862-76
19293287
Prog Retin Eye Res. 2009 Mar;28(2):87-116
19071227
Hepatology. 2009 Aug;50(2):575-84
19582816
Curr Genomics. 2009 May;10(3):184-93
19881911
Cancer Biol Ther. 2008 Jul;7(7):1146-56
18535405
Mol Cell. 2009 Sep 11;35(5):610-25
19748357
Nat Struct Mol Biol. 2009 Apr;16(4):365-71
19330006
Genome Biol. 2007;8(11):R248
18034880
Childs Nerv Syst. 2008 Apr;24(4):485-92
17962954
Biochem Biophys Res Commun. 2001 Aug 3;285(5):1200-5
11478782
Exp Eye Res. 1996 Feb;62(2):155-69
8698076
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):509-15
17251443
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4692-7
9114053
Cell Cycle. 2007 May 2;6(9):1001-5
17457051
Curr Protoc Bioinformatics. 2008 Mar;Chapter 2:Unit 2.6
18428685
Biochem Biophys Res Commun. 2002 Jun 28;294(5):956-61
12074569
Mamm Genome. 2008 Aug;19(7-8):510-6
18648874
Photochem Photobiol. 2004 May;79(5):470-5
15191057
Neuron. 2008 Jul 31;59(2):274-87
18667155
Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2706-13
11581219
Mol Cell Biol. 2009 Oct;29(19):5290-305
19635812
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):3962-7
17724173
J Cell Physiol. 2006 Dec;209(3):854-65
16972258
J Inorg Biochem. 2007 Sep;101(9):1265-9
17629564
Mol Ther. 2008 Jul;16(7):1208-16
18500251
J Biol Chem. 2006 Sep 15;281(37):26932-42
16831872
Nat Neurosci. 2008 Jun;11(6):641-8
18454145
J Pathol. 2008 Jan;214(1):17-24
17948228
Biochem J. 2006 Jul 15;397(2):345-53
16608438
Circulation. 2009 May 5;119(17):2357-2366
19380620
Cell. 2004 Jan 23;116(2):281-97
14744438
Prog Retin Eye Res. 2000 Mar;19(2):205-21
10674708
Hum Genomics. 2009 Jul;3(4):332-48
19706364
FEBS J. 2009 Oct;276(19):5537-46
19702828